About Sinopharm Online
Sinopharm Online is a Healthcare company based in Minhang (China) founded in 2015. Pharmaceutical products are sold via an e-commerce platform in China. Sinopharm Online has raised $62.35 million across 2 funding rounds from investors including ShenZhen GTJA Investment Group, One Village Capital and Ample Harvest Finance. Its chief executive, as recorded, is Wang Letian. Its focus areas include Pharmaceutical Distributors and Diversified. Its competitors include Dizal Pharma, Quanyuantang Pharmacy and Guiyang Xintian Pharmaceutical; 2 of its 3 listed competitors have raised funding.
Company details
Sinopharm Online was established in 2015 as a pharmaceutical e-commerce platform. Operations are centered in Minhang, China, where online sales of medications and health products are facilitated through the domain yao123.cn. Services include digital distribution to consumers and possibly healthcare providers in the pharmaceutical sector. The platform is led by CEO Wang Letian, with focus on streamlining access to pharmaceuticals across China.
- Headquarters Minhang, China
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website yao123.cn
- Total Equity Funding$62.35M (USD)
in 2 rounds
- Latest Funding Round$44.52M (USD), Series B
Apr 2019
- InvestorsShenZhen GTJA Investment Group
& 4 more
Funding Insights of Sinopharm Online
Sinopharm Online has successfully raised a total of $62.35M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $44.52 million completed in April 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $62.35M
- Total Rounds 2
- Last Round Series B — $44.52M
- First Round $17.84M
(Jul 2017)
- Investors Count 5
All 2 funding rounds of Sinopharm Online with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2019 | $44.52M | Series B | – | ShenZhen GTJA Investment Group | |
| Jul 2017 | $17.84M | Series A | – | Yunfeng Capital | – |
5 investors in total: 5 institutional.
Investors in Sinopharm Online
Sinopharm Online has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include ShenZhen GTJA Investment Group, One Village Capital and Ample Harvest Finance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| szgig.com | ||||
Private equity investments are managed by Yunfeng Capital in China. | yfc.cn | Shanghai, China | ||
| cnlsi.com | ||||
| v-capital.cn | ||||
Manages diversified investment portfolios across various asset classes. | 2011 | ample-harvest.com | Shanghai, China |
Investor details for Sinopharm Online
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Sinopharm Online
1 people are tracked at Sinopharm Online (1 in leadership).
| Name | Role | Group |
|---|---|---|
Wang Letian | CEO | Leadership |
Complete people profiles for Sinopharm Online
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Sinopharm Online
3 dated milestones of Sinopharm Online across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Sinopharm Online is founded.
- Funding First funding round of $17.8M.
- Funding Latest funding round, Series B, of $44.5M.
Competitors of Sinopharm Online
Sinopharm Online has 3 listed competitors in our database, 2 of them funded. They include Dizal Pharma, Quanyuantang Pharmacy and Guiyang Xintian Pharmaceutical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| dizalpharma.com | 2017 | Pudong, China | $100M | Pharmaceutical research and development are focused on oncology therapeutics. | ||
| qyt1902.com | 1902 | Chengdu, China | $76.05M | Medical and pharmaceutical products are retailed offline and online. | ||
| gyxtyy.com | 1995 | Guiyang, China | Pharmaceutical company in China |
Detailed competitors of Sinopharm Online
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Sinopharm Online
The website of Sinopharm Online (yao123.cn) receives about 1.1K visits a month.
- Monthly visits1.1K
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Sinopharm Online
Complete news archive for Sinopharm Online
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sinopharm Online
Sinopharm Online was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Sinopharm Online is headquartered in Minhang, China. It is registered at Minhang, Shanghai, China.
Wang Letian is the CEO of Sinopharm Online, as recorded in our data.
Sinopharm Online is a funded company, having raised a total of $62.35M across 2 funding rounds to date. The company's 1st funding round was a Series A of $17.84M, raised on Jul 2017.
Sinopharm Online was established in 2015 as a pharmaceutical e-commerce platform. Operations are centered in Minhang, China, where online sales of medications and health products are facilitated through the domain yao123.cn. Services include digital distribution to consumers and possibly healthcare providers in the pharmaceutical sector. The platform is led by CEO Wang Letian, with focus on streamlining access to pharmaceuticals across China.
Sinopharm Online's top competitors include Dizal Pharma, Guiyang Xintian Pharmaceutical and Quanyuantang Pharmacy.
Sinopharm Online has 5 investors. Key investors include ShenZhen GTJA Investment Group, One Village Capital, Ample Harvest Finance, Yunfeng Capital, and Lanxess Investment Group.